Reversion of cardiovascular remodelling in renovascular hypertensive 2K‐1C rats by renin–angiotensin system inhibitors

Evaluate whether the RAS dual blockade would induce additional beneficial effects on cardiovascular remodelling when compared to monotherapy in renal hypertensive two kidneys–one clip (2K‐1C) rats.

• Publication year

  2020

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2020-07-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1440-1681.13384PMID 32688435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [2018 ESC/ESH Guidelines for the management of arterial hypertension].

  2019cited by this paper
• Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

  2018cited by this paper
• 2018 ESC/ESH Guidelines for the management of arterial hypertension.

  2018cited by this paper
• [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

  2018cited by this paper
• Carthamus tinctorius L. extract improves hemodynamic and vascular alterations in a rat model of renovascular hypertension through Ang II-AT1R-NADPH oxidase pathway.

  2018cited by this paper
• Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy.

  2018cited by this paper
• Vascular Remodeling in Hypertension

  2017cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2017cited by this paper
• [A randomized trial of intensive versus standard blood pressure control].

  2016cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2016cited by this paper
• Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

  2016cited by this paper
• Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.

  2014cited by this paper
• Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.

  2013cited by this paper
• Irbesartan and Emodin on Myocardial Remodeling in Goldblatt Hypertensive Rats

  2012cited by this paper
• Vascular Remodeling in Hypertension: Mechanisms and Treatment

  2012cited by this paper
• Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension.

  2010cited by this paper
• Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

  2010cited by this paper
• Clinical impact of left ventricular hypertrophy and implications for regression.

  2009cited by this paper
• Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.

  2009cited by this paper
• Evidence for benefits of angiotensin receptor blockade beyond blood pressure control

  2008cited by this paper
• Oxidative stress contributes to renovascular hypertension.

  2008cited by this paper
• Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the ReninAngiotensin System on Proteinuria in Renal Disease

  2008cited by this paper
• Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress.

  2008cited by this paper
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

  2008cited by this paper
• Renovascular Hypertension: An Update

  2008cited by this paper
• Rationale for double renin-angiotensin-aldosterone system blockade.

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Phosphorylation of RyR2 and shortening of RyR2 cluster spacing in spontaneously hypertensive rat with heart failure.

  2007cited by this paper
• Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension

  2005cited by this paper
• Cardioprotective Action of Perindopril versus Candesartan in Renovascular Hypertensive Rats

  2004cited by this paper
• Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

  2004cited by this paper
• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  2003cited by this paper
• Ac-SDKP Reverses Cardiac Fibrosis in Rats With Renovascular Hypertension

  2003cited by this paper
• Beyond blood pressure: the endothelium and atherosclerosis progression.

  2002cited by this paper
• Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Myocyte growth and cardiac repair.

  2002cited by this paper
• Effects of Combination of ACE Inhibitor and Angiotensin Receptor Blocker on Cardiac Remodeling, Cardiac Function, and Survival in Rat Heart Failure

  2001cited by this paper
• Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.

  2001cited by this paper
• Ca2+ Influx is Increased in 2-Kidney, 1-Clip Hypertensive Rat Aorta

  2001cited by this paper
• Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension.

  2000cited by this paper
• Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat.

  2000cited by this paper
• Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

  2000cited by this paper
• [Vascular remodeling].

  2000cited by this paper
• Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.

  2000cited by this paper
• Endothelin system-dependent cardiac remodeling in renovascular hypertension.

  1999cited by this paper
• Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.

  1999cited by this paper
• Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

  1999cited by this paper
• Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.

  1997cited by this paper
• Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade.

  1996cited by this paper
• The Renin–Angiotensin System in the Heart and Vascular Wall: New Therapeutic Aspects

  1994cited by this paper
• Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

  1994cited by this paper
• Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

  1994cited by this paper
• Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

  1993cited by this paper
• Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

  1993cited by this paper
• Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy.

  1992cited by this paper
• Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena?

  1991cited by this paper
• Experimental Cardiovascular Benefits of Angiotensin‐Converting Enzyme Inhibitors: Beyond Blood Pressure Reduction

  1991cited by this paper
• Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart.

  1990cited by this paper
• Remodeling of the rat right and left ventricles in experimental hypertension.

  1990cited by this paper
• Combined Renin and Converting Enzyme Inhibition in Rats

  1989cited by this paper
• Cellular Basis of Wall Remodeling in Long‐term Pressure Overload‐Induced Right Ventricular Hypertrophy in Rats

  1988cited by this paper
• Regression of cardiac hypertrophy. Experimental animal model.

  1983cited by this paper
• The effect of iron deficiency anemia in the rat on catecholamine levels and heart morphology.

  1981cited by this paper

• Antihypertensive Effects of Diosmetin in Hypertension-Induced Cardiovascular Abnormalities in Rats

  2025cites this paper
• Luteolin restores the renin-angiotensin system to alleviate blood pressure and cardiac changes in secondary hypertensive rats

  2025cites this paper
• Comparative Analysis of Hypertensive Tubulopathy in Animal Models of Hypertension and Its Relevance to Human Pathology

  2023cites this paper
• BmooMPα-I, a Metalloproteinase Isolated from Bothrops moojeni Venom, Reduces Blood Pressure, Reverses Left Ventricular Remodeling and Improves Cardiac Electrical Conduction in Rats with Renovascular Hypertension

  2022cites this paper
• Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy

  2022cites this paper
• Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats

  2021cites this paper
• Clitoria ternatea (Linn.) flower extract attenuates vascular dysfunction and cardiac hypertrophy via modulation of Ang II/AT1 R/TGF-β1 cascade in hypertensive rats.

  2021cites this paper